Your browser doesn't support javascript.
loading
Regulatory CD8 T cells that recognize Qa-1 expressed by CD4 T-helper cells inhibit rejection of heart allografts.
Choi, John Y; Eskandari, Siawosh K; Cai, Songjie; Sulkaj, Ina; Assaker, Jean Pierre; Allos, Hazim; AlHaddad, Juliano; Muhsin, Saif A; Alhussain, Eman; Mansouri, Amr; Yeung, Melissa Y; Seelen, Marc A J; Kim, Hye-Jung; Cantor, Harvey; Azzi, Jamil R.
Afiliación
  • Choi JY; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Eskandari SK; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Cai S; Division of Nephrology, University Medical Center Groningen, University of Groningen, 9700 AB Groningen, The Netherlands.
  • Sulkaj I; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Assaker JP; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Allos H; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • AlHaddad J; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Muhsin SA; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Alhussain E; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Mansouri A; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Yeung MY; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Seelen MAJ; Division of Renal Medicine, Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
  • Kim HJ; Division of Nephrology, University Medical Center Groningen, University of Groningen, 9700 AB Groningen, The Netherlands.
  • Cantor H; Department of Cancer Immunology & Virology, Dana-Farber Cancer Institute, Boston, MA 02215.
  • Azzi JR; Department of Immunology, Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A ; 117(11): 6042-6046, 2020 03 17.
Article en En | MEDLINE | ID: mdl-32111690
ABSTRACT
Induction of longstanding immunologic tolerance is essential for survival of transplanted organs and tissues. Despite recent advances in immunosuppression protocols, allograft damage inflicted by antibody specific for donor organs continues to represent a major obstacle to graft survival. Here we report that activation of regulatory CD8 T cells (CD8 Treg) that recognize the Qa-1 class Ib major histocompatibility complex (MHC), a mouse homolog of human leukocyte antigen-E (HLA-E), inhibits antibody-mediated immune rejection of heart allografts. We analyzed this response using a mouse model that harbors a point mutation in the class Ib MHC molecule Qa-1, which disrupts Qa-1 binding to the T cell receptor (TCR)-CD8 complex and impairs the CD8 Treg response. Despite administration of cytotoxic T lymphocyte antigen 4 (CTLA-4) immunoglobulin (Ig), Qa-1 mutant mice developed robust donor-specific antibody responses and accelerated heart graft rejection. We show that these allo-antibody responses reflect diminished Qa-1-restricted CD8 Treg-mediated suppression of host follicular helper T cell-dependent antibody production. These findings underscore the critical contribution of this Qa-1/HLA-E-dependent regulatory pathway to maintenance of transplanted organs and suggest therapeutic approaches to ameliorate allograft rejection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Trasplante de Corazón / Linfocitos T Reguladores / Linfocitos T Colaboradores-Inductores / Rechazo de Injerto Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Trasplante de Corazón / Linfocitos T Reguladores / Linfocitos T Colaboradores-Inductores / Rechazo de Injerto Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article